Prognostic factors in advanced incurable HNSCC patients on palliative-intent immunotherapy-based regimen
SII, albumin, and BMI were the strongest independent prognostic factors of overall survival in rmHNSCC patients treated with palliative immunotherapy. Future validation studies would be important, given these are inexpensive, noninvasive tests and may be potentially modifiable patient factors.
Authors
- Haseeb Faisal (ORCID: https://orcid.org/0000-0002-4749-1754)
- Courtney H. Coschi
- Shadi Sadeghian
- Michelle Bradbury
- Francesco Fazzari (ORCID: https://orcid.org/0000-0002-6780-3129)
- Gregory R. Pond (ORCID: https://orcid.org/0000-0003-1033-0882)
- Adi Kartolo (ORCID: https://orcid.org/0000-0002-6303-5206)
- Brandon M. Meyers (ORCID: https://orcid.org/0000-0001-9673-6271)
- Zainab Al Maqrashi
- Sze Wah Samuel Chan (ORCID: https://orcid.org/0000-0001-9167-9431)
- Yazeed AlHarbi
- Adam Gabara
Institutions
- McMaster University (CA)
Publication Details
- Journal
- Future Science OA
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1080/20565623.2025.2552067
- Citations
- 2
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.70